epidemiology in cancer

Upload: dawn-moran

Post on 02-Jun-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/11/2019 Epidemiology in Cancer

    1/35

    Epidemiology in Cancer

  • 8/11/2019 Epidemiology in Cancer

    2/35

    Picture of Cells Nucleus

  • 8/11/2019 Epidemiology in Cancer

    3/35

  • 8/11/2019 Epidemiology in Cancer

    4/35

  • 8/11/2019 Epidemiology in Cancer

    5/35

  • 8/11/2019 Epidemiology in Cancer

    6/35

    Make a metaphase

    or interphase

    spread

    Identify and line up

    each chromosome

    pairs side by side

    Look for structure

    abnormalities

    Picture of Chromosomes

  • 8/11/2019 Epidemiology in Cancer

    7/35

    Chromosomes comes in Pair one

    from dad and one from mom

  • 8/11/2019 Epidemiology in Cancer

    8/35

  • 8/11/2019 Epidemiology in Cancer

    9/35

  • 8/11/2019 Epidemiology in Cancer

    10/35

  • 8/11/2019 Epidemiology in Cancer

    11/35

  • 8/11/2019 Epidemiology in Cancer

    12/35

    opr05TIB.swf

    http://localhost/var/www/apps/conversion/tmp/scratch_8/opr05TIB.swfhttp://localhost/var/www/apps/conversion/tmp/scratch_8/opr05TIB.swf
  • 8/11/2019 Epidemiology in Cancer

    13/35

  • 8/11/2019 Epidemiology in Cancer

    14/35

  • 8/11/2019 Epidemiology in Cancer

    15/35

  • 8/11/2019 Epidemiology in Cancer

    16/35

  • 8/11/2019 Epidemiology in Cancer

    17/35

  • 8/11/2019 Epidemiology in Cancer

    18/35

  • 8/11/2019 Epidemiology in Cancer

    19/35

  • 8/11/2019 Epidemiology in Cancer

    20/35

    Knudsen Two Hits Hypothesis

  • 8/11/2019 Epidemiology in Cancer

    21/35

    Oncogenesis

    Statistic based predictionRetinoblastoma is genotypically recessive,only manifest when both Rb gene copies aremutated ie genotype is rb/rb, carrier (i.g.RB/rb) are normal

    Descendents from a carrier and a normal

    parent theoritically should be 0% forRetinoblastoma

    Observation

    50% of the children develop

    Retinoblastoma

    Two Steps (Hits) Oncogenesis

    Introduction

  • 8/11/2019 Epidemiology in Cancer

    22/35

    OncogenesisTwo Steps (Hits) Oncogenesis

    Introduction

    Genotype Clinical

    Children

    Tumor

    Germline

    Somatic

    0%RB?

    50%RB!

    2 Hits : Germline inactivating mutation in previous

    generation + somatic inactivating mutation in tumor

    RB/rb

    RB/rb

    RB/RB

    RB/RB

    rb/rb

  • 8/11/2019 Epidemiology in Cancer

    23/35

    Is all cancer one genic?

    Nope

  • 8/11/2019 Epidemiology in Cancer

    24/35

    Multistep oncogenesis Pathway

  • 8/11/2019 Epidemiology in Cancer

    25/35

  • 8/11/2019 Epidemiology in Cancer

    26/35

    Animation of Oncogenesis

    ..\My Documents\pasca\S2-FIK\immunitas

    kanker\grows.swf

    ..\My Documents\pasca\S2-FIK\immunitas

    kanker\breastcancer.swf

    http://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swf
  • 8/11/2019 Epidemiology in Cancer

    27/35

  • 8/11/2019 Epidemiology in Cancer

    28/35

    Rate of genomic Mutations is low

    So how is it possible to get cancer if

  • 8/11/2019 Epidemiology in Cancer

    29/35

    So how is it possible to get cancer if

    there are too many pathways need to

    be disrupted to generate one The persons genome need to be in a state

    that is unstable. Easily mutating by

    itself!!

    = Genomic Instability

    Or being mutated continuously from

    outside = radiation exposure. Chernobylfor example

  • 8/11/2019 Epidemiology in Cancer

    30/35

  • 8/11/2019 Epidemiology in Cancer

    31/35

    Pathways to malignancy

    Genomic Instability Pathway

    Barriers are the

    two hits

    TSG Recql4,

    BLM, WRN

    OG : any genes

    that promote

    genomic

    instability

  • 8/11/2019 Epidemiology in Cancer

    32/35

  • 8/11/2019 Epidemiology in Cancer

    33/35

    Epid Early detection: So who are

    the predisposed group?

    People with familial cancer history

    Same type of cancer Breast cancer for BRAC1/2

    Retinoblastoma MSI and APC for colonic Cancer

    Different type of cancer P53

    Req1lc Bloom Syndrome

    Werner Syndrome

  • 8/11/2019 Epidemiology in Cancer

    34/35

    What to do in the presence ofpredisposing factors?

    Regular screening for progression genetic

    abnormalities by cytogenetics.

    Molecular genetics work up for critical genes in the

    absence of cytogenetic evidence

    - Southern Blot

    - SSCP

    Epigenetics work up in the absence of cytogenetic and

    genetics evidence.

    Regular Radiologic or bone scan work up

  • 8/11/2019 Epidemiology in Cancer

    35/35

    Epidemiology in action